tradingkey.logo
tradingkey.logo
Pesquisar

STAAR Surgical Co

STAA
Adicionar à lista de desejos
32.070USD
+0.060+0.19%
Fechamento 05/15, 16:00ETCotações atrasadas em 15 min
1.59BValor de mercado
PerdaP/L TTM

Mais detalhes de STAAR Surgical Co Empresa

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.

Informações de STAAR Surgical Co

Código da empresaSTAA
Nome da EmpresaSTAAR Surgical Co
Data de listagemFeb 24, 1992
CEOFarrell (Stephen C)
Número de funcionários1157
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 24
Endereço1911 Walker Ave
CidadeMONROVIA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal91016
Telefone16263037902
Sitehttps://www.staar.com/
Código da empresaSTAA
Data de listagemFeb 24, 1992
CEOFarrell (Stephen C)

Executivos da empresa STAAR Surgical Co

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
82.21K
+57.24%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
67.50K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
53.33K
-6.47%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
30.18K
+72.87%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
23.32K
-7.20%
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
5.10K
--
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
82.21K
+57.24%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
67.50K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
53.33K
-6.47%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
30.18K
+72.87%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
23.32K
-7.20%
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
Others
93.84M
39.19%
China
77.78M
32.48%
Japan
45.27M
18.90%
U. S.
22.56M
9.42%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: qui, 14 de mai
Atualizado em: qui, 14 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Broadwood Capital, Inc.
32.38%
BlackRock Institutional Trust Company, N.A.
13.44%
Yunqi Capital Limited
6.54%
Madison Avenue Partners LP
5.73%
Magnetar Capital Partners LP
4.97%
Outro
36.94%
Investidores
Investidores
Proporção
Broadwood Capital, Inc.
32.38%
BlackRock Institutional Trust Company, N.A.
13.44%
Yunqi Capital Limited
6.54%
Madison Avenue Partners LP
5.73%
Magnetar Capital Partners LP
4.97%
Outro
36.94%
Tipos de investidores
Investidores
Proporção
Hedge Fund
53.68%
Investment Advisor
31.49%
Investment Advisor/Hedge Fund
21.11%
Research Firm
6.23%
Pension Fund
1.00%
Individual Investor
0.66%
Bank and Trust
0.36%
Venture Capital
0.06%
Insurance Company
0.02%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
543
58.06M
116.62%
-10.58M
2025Q4
536
52.38M
105.30%
-16.01M
2025Q3
511
49.83M
100.45%
-14.96M
2025Q2
543
53.99M
109.59%
-5.64M
2025Q1
586
53.67M
108.47%
-5.73M
2024Q4
611
49.68M
100.75%
-8.34M
2024Q3
633
50.35M
102.36%
-6.37M
2024Q2
636
49.69M
101.15%
-10.70M
2024Q1
632
50.54M
103.45%
-9.24M
2023Q4
640
52.70M
107.96%
-9.84M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Broadwood Capital, Inc.
16.12M
32.56%
+670.21K
+4.34%
Mar 13, 2026
BlackRock Institutional Trust Company, N.A.
6.69M
13.51%
+107.78K
+1.64%
Dec 31, 2025
Yunqi Capital Limited
3.26M
6.58%
+750.00K
+29.91%
Jan 14, 2026
Magnetar Capital Partners LP
2.47M
4.99%
+1.27M
+105.28%
Dec 31, 2025
Goldman Sachs & Company, Inc.
1.97M
3.98%
+1.11M
+128.32%
Dec 31, 2025
State Street Investment Management (US)
1.94M
3.92%
+29.50K
+1.54%
Dec 31, 2025
Balyasny Asset Management LP
1.54M
3.11%
-272.35K
-15.02%
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
AltShares Merger Arbitrage ETF
2.71%
ProShares Merger ETF
2.53%
State Street SPDR S&P Health Care Equipment ETF
1.67%
NYLI Merger Arbitrage ETF
0.87%
Invesco S&P SmallCap Health Care ETF
0.79%
Royce Quant Small-Cap Quality Value ETF
0.26%
State Street SPDR S&P SmallCap 600 ESG ETF
0.13%
iShares S&P Small-Cap 600 Growth ETF
0.1%
State Street SPDR S&P 600 Small Cap Growth ETF
0.1%
iShares ESG Select Screened S&P Small-Cap ETF
0.1%
Ver Mais
AltShares Merger Arbitrage ETF
Proporção2.71%
ProShares Merger ETF
Proporção2.53%
State Street SPDR S&P Health Care Equipment ETF
Proporção1.67%
NYLI Merger Arbitrage ETF
Proporção0.87%
Invesco S&P SmallCap Health Care ETF
Proporção0.79%
Royce Quant Small-Cap Quality Value ETF
Proporção0.26%
State Street SPDR S&P SmallCap 600 ESG ETF
Proporção0.13%
iShares S&P Small-Cap 600 Growth ETF
Proporção0.1%
State Street SPDR S&P 600 Small Cap Growth ETF
Proporção0.1%
iShares ESG Select Screened S&P Small-Cap ETF
Proporção0.1%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI